NEWS

Pharma company chooses chemistry software platform

ChemAxon, a provider of chemistry software solutions and consulting services for life science research, has announced that Boehringer Ingelheim has chosen its chemistry software platform for multiple applications across research and development, supporting in-house activities and work with external collaboration partners.

ChemAxon technology will be used to store, search, calculate, and visualise chemical entities, properties and reactions, helping to streamline the progression from drug discovery to clinical candidate. ChemAxon was chosen after an extensive evaluation process that built on dimensions such as ROI, performance, robustness, scalability and future development roadmap.

ChemAxon provides chemically-intelligent software for pharmaceutical R&D. With a client list that includes all of the top 15 global pharma companies, the company continues to experience significant growth.

Alex Drijver, CEO of ChemAxon said: 'The adoption of ChemAxon technology by Boehringer Ingelheim further underlines our position as the platform of choice for R&D organisations planning their next-generation systems.'

Twitter icon
Google icon
Del.icio.us icon
Digg icon
LinkedIn icon
Reddit icon
e-mail icon
Feature

Sophia Ktori investigates the use of informatics software to increase data integrity in the laboratory

Feature

Tim Gillett reports from PRACEDays 2016, held in May in the city of Prague

Feature

Robert Roe investigates the motivation behind the architectural changes to Europes fastest supercomputer, Piz Daint, housed at the Swiss National Computing Centre

Feature

Robert Roe discusses the merits of the latest storage technologies, including a push by storage providers to develop end-to-end platforms featuring intelligent data management systems

Feature

As AMD launches its latest FirePro GPU, Robert Roe investigates a new suite of open-source tools, released by the company that convert code from CUDA into C++